IZMAILOV, A.A.,
BEILERLI, O.A.,
V.N. Pavlov,
GAREEV, I.F.,
ZABELIN, M.V.,
AYUPOV, R.T.,
MUSIN, S.,
SULTANBAEV, A.V. (2020) for the management of
cancer patients based on the experience of the medical staff of the Regional Clinical Oncology
Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) Breast
cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial
YAN, G.,
ZHANG, L.,
FENG, C.,
GONG, R.,
HUANG, Q.,
HE, M.,
YANG, F.,
LI, Y.,
DING, F.,
MA, W.,
HAN, Z.,
WANG, Z.,
YUAN, Y.,
CAI, B.,
YANG, L.,
GUO, S.,
V.N. Pavlov,
XU, C.,
IDIIATULLINA, E (2018) strategies for
several diseases. However, the blue LED effects remain largely unknown in colorectal
cancer